FTC brings first product-hopping claim in Suboxone settlement
As part of a settlement to resolve criminal and civil liability for its marketing of Suboxone, Reckitt Benckiser has agreed to a Federal Trade Commission order to pay $50 million and change conduct that allegedly blocked generic competition to the opioid addiction treatment.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10